Graham Wardlow - 20 May 2025 Form 4 Insider Report for LUXFER HOLDINGS PLC (LXFR)

Role
Officer
Signature
/s/ Benjamin Coulson under Power of Attorney for Graham Wardlow
Issuer symbol
LXFR
Transactions as of
20 May 2025
Net transactions value
-$173,861
Form type
4
Filing time
22 May 2025, 06:08:48 UTC
Previous filing
20 Mar 2025
Next filing
23 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Wardlow Graham Officer LUXFER HOLDINGS PLC, LUMNS LANE, MANCHESTER, UNITED KINGDOM /s/ Benjamin Coulson under Power of Attorney for Graham Wardlow 22 May 2025 0001761477

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXFR Ordinary Shares Options Exercise +928 +3.2% 29,936 20 May 2025 Direct F1
transaction LXFR Ordinary Shares Options Exercise +1,128 +3.8% 31,064 20 May 2025 Direct F1
transaction LXFR Ordinary Shares Options Exercise +1,250 +4% 32,314 20 May 2025 Direct F1
transaction LXFR Ordinary Shares Options Exercise +1,885 +5.8% 34,199 20 May 2025 Direct F1
transaction LXFR Ordinary Shares Options Exercise +1,280 +3.7% 35,479 20 May 2025 Direct F1
transaction LXFR Ordinary Shares Options Exercise +2,304 +6.5% 37,783 20 May 2025 Direct F1
transaction LXFR Ordinary Shares Options Exercise +900 +2.4% 38,683 20 May 2025 Direct F1
transaction LXFR Ordinary Shares Sale $58,244 -4,874 -13% $11.95 33,809 20 May 2025 Direct
holding LXFR Ordinary Shares 7,520 20 May 2025 By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXFR Stock Options (Right to Buy) Options Exercise $11,090 -928 -100% $11.95 0 20 May 2025 Ordinary Shares 928 Direct F1, F2
transaction LXFR Stock Options (Right to Buy) Options Exercise $13,480 -1,128 -53% $11.95 1,000 20 May 2025 Ordinary Shares 1,128 Direct F1, F3
transaction LXFR Stock Options (Right to Buy) Options Exercise $14,938 -1,250 -35% $11.95 2,300 20 May 2025 Ordinary Shares 1,250 Direct F1, F4
transaction LXFR Stock Options (Right to Buy) Options Exercise $22,526 -1,885 -26% $11.95 5,430 20 May 2025 Ordinary Shares 1,885 Direct F1, F5
transaction LXFR Stock Options (Right to Buy) Options Exercise $15,296 -1,280 -100% $11.95 0 20 May 2025 Ordinary Shares 1,280 Direct F1, F6
transaction LXFR Stock Options (Right to Buy) Options Exercise $27,533 -2,304 -100% $11.95 0 20 May 2025 Ordinary Shares 2,304 Direct F1, F7
transaction LXFR Stock Options (Right to Buy) Options Exercise $10,755 -900 -100% $11.95 0 20 May 2025 Ordinary Shares 900 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 1 for 1, subject to a nominal payment of $1.00 per Ordinary Share.
F2 Represents the exercise of time-based Stock Options awarded on March 15, 2021. The subject Stock Options vested and were exercisable as of March 15, 2025.
F3 Represents the exercise of time-based Stock Options awarded on March 14, 2022. The subject Stock Options vested and were exercisable as of March 14, 2025. The remaining Stock Options vest and become exercisable on March 14, 2026.
F4 Represents the exercise of time-based Stock Options awarded on March 20, 2023. The subject Stock Options vested and were exercisable as of March 20, 2025. The remaining Stock Options vest in two equal annual installments beginning on March 20, 2026
F5 Represents the exercise of time-based Stock Options awarded on March 18, 2024. The subject Stock Options vested and were exercisable as of March 18, 2025. The remaining Stock Options vest in three equal annual installments beginning on March 18, 2026.
F6 Represents the grant of performance-based Stock Options (at 200% target) upon the achievement of an adjusted diluted EPS performance metric for the performance period ended December 31, 2021. One-third of the performance-based Stock Options, being 1,280 Stock Options, vested on March 15, 2023., March 15, 2024 and March15, 2025.
F7 Represents the grant and full vesting of performance-based Stock Options (at 96% target) awarded on March 14, 2022. 100% of the performance-based Stock Options vested on March 14, 2025 upon the achievement of Earnings Per Share (EPS) Growth goals for the three-year performance period ended December 31, 2024.
F8 Represents the grant and full vesting of performance-based Stock Options (at 25% target) awarded on March 14, 2022. 100% of the performance-based Stock Options vested on March 14, 2025 upon the achievement of Total Shareholder Return (TSR) goals for the three-year performance period ended December 31, 2024.